HomeINDP • NASDAQ
add
Indaptus Therapeutics Inc
Previous close
$1.76
Day range
$1.62 - $1.79
Year range
$1.52 - $22.54
Market cap
3.81M USD
Avg Volume
40.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.16M | 95.51% |
Net income | -8.11M | -96.38% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.16M | -95.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.51M | 47.02% |
Total assets | 9.31M | 26.86% |
Total liabilities | 6.16M | 81.46% |
Total equity | 3.15M | — |
Shares outstanding | 2.24M | — |
Price to book | 1.21 | — |
Return on assets | -252.49% | — |
Return on capital | -525.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.11M | -96.38% |
Cash from operations | -3.19M | 6.04% |
Cash from investing | — | — |
Cash from financing | 5.87M | 225.92% |
Net change in cash | 2.68M | 268.26% |
Free cash flow | -1.93M | -12.97% |
About
Founded
2021
Website
Employees
7
